quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:39:33·30d
ANALYSTRating
Generate Biomedicines Inc. logo

Cantor Fitzgerald initiated coverage on Generate Biomedicines

GENB· Generate Biomedicines Inc.
Health Care
Original source

Companies

  • GENB
    Generate Biomedicines Inc.
    Health Care

Recent analyst ratings

  • Apr 13UpdateH.C. Wainwright$16.00
  • Mar 24UpdatePiper Sandler$24.00
  • Mar 24UpdateMorgan Stanley$20.00
  • Mar 24UpdateCantor Fitzgerald-
  • Mar 24UpdateGuggenheim$30.00
  • Mar 24UpdateGoldman$26.00

Related

  • ANALYST10d
    H.C. Wainwright initiated coverage on Generate Biomedicines with a new price target
  • ANALYST30d
    Piper Sandler initiated coverage on Generate Biomedicines with a new price target
  • ANALYST30d
    Morgan Stanley initiated coverage on Generate Biomedicines with a new price target
  • ANALYST30d
    Guggenheim initiated coverage on Generate Biomedicines with a new price target
  • ANALYST30d
    Goldman initiated coverage on Generate Biomedicines with a new price target
  • INSIDER42d
    New insider Pioneering Medicines 02, Llc claimed ownership of 1,562,500 shares (SEC Form 3)
  • INSIDER48d
    Chief Executive Officer Nally Michael bought $240,000 worth of shares (20,000 units at $12.00), increasing direct ownership by 4% to 572,707 units (SEC Form 4)
  • INSIDER52d
    SEC Form 4 filed by Director Vessey Rupert
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022